Today’s Market Winners And Losers (6/21/2012)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

While the Dow Jones Industrial Average, S&P 500 and NASDAQ are down slightly today after weak data on the U.S. labor market.  Nevertheless, there are several big winners and losers as of midday. Three of four of today’s featured stocks are in healthcare, two of which are in pharmaceuticals. Here are the midday big winners and losers.


 

Biggest Winners

Shares of Onyx Pharmaceuticals (NASDAQ: ONXX) are up 37.82% to $62.33 based on trading volume of approximately 15 million shares. The company’s cancer drug, carfilzomb, received an 11 to 1 vote from a Food & Drug Administration advisory panel in favor of approval. The FDA is expected to make a final decision by next month.

Shares of Sun Healthcare Group (NASDAQ: SUNH) are up 36.16% to $8.36 on trading volume of nearly 17 million shares. The company announced Wednesday that it would be acquired by privately held Genesis HealthCare for $273.3 million. The merging of the nursing home operators will consist of 400 facilities throughout the U.S.


Biggest Losers

Shares of Bed Bath and Beyond (NASDAQ: BBBY) are down 14.89% to 62.70 based on trading volume of 7.9 million shares. The retailer predicted Wednesday its second-quarters earning would be between 97 cents and $1.03 a share, down from $1.08 that the street was expecting.

Shares of Celgene (NASDAQ: CELG) are down 11.41% to $59.50 based on trading volume of 12 million shares. The company withdrew an application to market its cancer drug, Revlimid, in the European Union. The company said it now plans on seeking approval in 2013 instead of 2012.

Sam Weigley

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618